Cellcolabs: Difference between revisions

From Research Wiki
Newer edit →
Restructured wiki
 
Added valuation: ~€30-50M ($12M raised)
Line 12: Line 12:


== Funding ==
== Funding ==
'''Valuation:''' ~€30-50M ($12M raised)
$12 million (October 2025). Earlier rounds included €10.3 million.<ref>EU-Startups (Oct 27, 2025): "€10.3 million boost for Sweden's Cellcolabs to lower global stem cell costs by 90%"</ref>
$12 million (October 2025). Earlier rounds included €10.3 million.<ref>EU-Startups (Oct 27, 2025): "€10.3 million boost for Sweden's Cellcolabs to lower global stem cell costs by 90%"</ref>


Revision as of 07:42, 14 April 2026

Template:Company

What They Do

Scalable stem cell manufacturing to lower global stem cell costs by 90%.[1]

Funding

Valuation: ~€30-50M ($12M raised) $12 million (October 2025). Earlier rounds included €10.3 million.[2]

Key Relationship

Bryan Johnson's go-to stem cell provider.[3]

See Also

  1. ↑ Sifted (Oct 2025): "Bryan Johnson's go-to stem cell startup Cellcolabs lands $12m for worldwide rollout"
  2. ↑ EU-Startups (Oct 27, 2025): "€10.3 million boost for Sweden's Cellcolabs to lower global stem cell costs by 90%"
  3. ↑ Sifted, Oct 2025
Retrieved from "https://wiki.stamen.health/index.php?title=Cellcolabs&oldid=225"